TRPX - セラピクス・バイオサイエンシズ (Therapix Biosciences Ltd.)

TRPXのニュース

   Therapix Biosciences raises $2.6M in private placement (NASDAQ:TRPX)  2020/06/29 13:34:50 Seeking Alpha
Therapix Biosciences (NASDAQ:TRPX) entered into definitive agreements for the issuance of an aggregate of 5.2M ADSs at a purchase price of $0.50/ADS, and w
   Therapix Biosciences Raises $2.6 Million in Private Placement  2020/06/29 13:10:00 PR Newswire
TEL-AVIV, Israel, June 29, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced that it has entered into definitive…
   Therapix Biosciences Closes A Joint Venture Transaction For its Sleep Indication  2020/05/19 12:30:00 PR Newswire
TEL AVIV, Israel, May 19, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company" or "Therapix"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that it has closed a joint venture…
   Therapix Biosciences Appoints Prof. Ari Shamiss (M.D., M.P.A.) to the Company's Board of Directors  2020/05/07 22:04:00 PR Newswire
TEL AVIV, Israel, May 7, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announces today the appointment of Prof. Ari Shamiss (M.D., M.P.A.) to the…
   Therapix Biosciences Announces Appointment of New CEO  2020/04/22 20:30:00 PR Newswire
TEL AVIV, Israel, April 22, 2020 /PRNewswire/ -- Therapix Biosciences Ltd. (Nasdaq: TRPX) (the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the appointment of Mr. Gilad Bar-Lev as CEO of the…

calendar